JPMorgan Chase & Co’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19.6M | Buy |
|
|||||
|
2025
Q1 | $14.6M | Sell |
|
|||||
|
2024
Q4 | $17.1M | Sell |
|
|||||
|
2024
Q3 | $19.1M | Buy |
|
|||||
|
2024
Q2 | $14.9M | Sell |
|
|||||
|
2024
Q1 | $15.6M | Buy |
|
|||||
|
2023
Q4 | $15.1M | Buy |
|
|||||
|
2023
Q3 | $12.1M | Sell |
|
|||||
|
2023
Q2 | $12.4M | Sell |
|
|||||
|
2023
Q1 | $10.7M | Buy |
|
|||||
|
2022
Q4 | $12.9M | Sell |
|
|||||
|
2022
Q3 | $7.67M | Sell |
|
|||||
|
2022
Q2 | $6.73M | Sell |
|
|||||
|
2022
Q1 | $7.29M | Buy |
|
|||||
|
2021
Q4 | $6.62M | Buy |
|
|||||
|
2021
Q3 | $871K | Buy |
|
|||||
|
2021
Q2 | $1.7M | Buy |
|
|||||
|
2021
Q1 | $1.33M | Sell |
|
|||||
|
2020
Q4 | $1.94M | Buy |
|
|||||
|
2020
Q3 | $753K | Buy |
|
|||||
|
2020
Q2 | $779K | Buy |
|
|||||
|
2020
Q1 | $514K | Buy |
|
|||||
|
2019
Q4 | $837K | Sell |
|
|||||
|
2019
Q3 | $921K | Buy |
|
|||||
|
2019
Q2 | $170K | Buy |
|
|||||
|
2019
Q1 | – | Hold |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $140K | Sell |
|
|||||
|
2018
Q2 | $261K | Sell |
|
|||||
|
2018
Q1 | $442K | Sell |
|
|||||
|
2017
Q4 | $8.15M | Sell |
|
|||||
|
2017
Q3 | $8.03M | Buy |
|
|||||
|
2017
Q2 | $7.9M | Sell |
|
|||||
|
2017
Q1 | $6.22M | Sell |
|
|||||
|
2016
Q4 | $10.8M | Buy |
|
|||||
|
2016
Q3 | $12.6M | Buy |
|
|||||
|
2016
Q2 | $11.9M | Sell |
|
|||||
|
2016
Q1 | $13.6M | Buy |
|
|||||
|
2015
Q4 | $14.2M | Buy |
|